Allurion Technologies Inc (ALUR)
1.88
+0.02
(+1.08%)
USD |
NYSE |
May 17, 16:00
1.90
+0.02
(+1.06%)
Pre-Market: 20:00
Allurion Technologies Cash from Operations (Quarterly): -8.636M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.636M |
| December 31, 2023 | -20.87M |
| September 30, 2023 | -23.09M |
| June 30, 2023 | -9.699M |
| March 31, 2023 | -10.32M |
| Date | Value |
|---|---|
| December 31, 2022 | -15.73M |
| September 30, 2022 | -10.13M |
| June 30, 2022 | -12.03M |
| March 31, 2022 | -9.098M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-23.09M
Minimum
Sep 2023
-8.636M
Maximum
Mar 2024
-13.29M
Average
-10.32M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Outset Medical Inc | -45.91M |
| Paragon 28 Inc | -10.99M |
| Perspective Therapeutics Inc | 13.85M |
| Xtant Medical Holdings Inc | -5.755M |
| Asensus Surgical Inc | -14.01M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.104M |
| Cash from Financing (Quarterly) | 0.387M |
| Free Cash Flow | -63.73M |
| Free Cash Flow Per Share (Quarterly) | -0.1777 |
| Free Cash Flow to Equity (Quarterly) | -9.054M |
| Free Cash Flow to Firm (Quarterly) | -6.835M |
| Free Cash Flow Yield | -78.41% |